 | • レポートコード：QAF27635 • 出版社/出版日：QYResearch / 2021年4月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の細胞毒性薬市場について種類別（注射、固形経口剤形、その他）、用途別（乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・細胞毒性薬市場の概要 ・世界の主要地域別細胞毒性薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の細胞毒性薬市場規模2016-2021：種類別（注射、固形経口剤形、その他） ・世界の細胞毒性薬市場予測2012-2027：種類別（注射、固形経口剤形、その他） ・世界の細胞毒性薬市場規模2016-2021：用途別（乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他） ・世界の細胞毒性薬市場予測2012-2027：用途別（乳がん、血液がん、前立腺がん、呼吸器・肺がん、その他） ・細胞毒性薬のアメリカ市場規模と予測2016-2021 ・細胞毒性薬のヨーロッパ市場規模と予測2016-2021 ・細胞毒性薬の中国市場規模と予測2016-2021 ・細胞毒性薬の日本市場規模と予測2016-2021 ・細胞毒性薬の東南アジア市場規模と予測2016-2021 ・細胞毒性薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、Eli Lilly、Celgene、Sanofi、eisai、Sumitomo Dainippon Pharma、Merck、Seattle Genetics、Takeda、Haosoh Pharma、Novartis、AstraZeneca、Jazz Pharma、Spectrum Pharma） ・細胞毒性薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・細胞毒性薬の市場動向・機会・課題 ・調査の結論 |
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection in 2016 is about 94%, and the proportion is in decreasing trend from 2012 to 2016.
Market Analysis and Insights: Global Cytotoxic Drug Market
The global Cytotoxic Drug market was valued at US$ 14470 in 2020 and will reach US$ 15360 million by the end of 2027, growing at a CAGR of 1.0% during 2022-2027.
Global Cytotoxic Drug Scope and Market Size
The global Cytotoxic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cytotoxic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injection
Solid Oral Dose Forms
Others
Segment by Application
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
The Cytotoxic Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Cytotoxic Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
1 Cytotoxic Drug Market Overview
1.1 Cytotoxic Drug Product Scope
1.2 Cytotoxic Drug Segment by Type
1.2.1 Global Cytotoxic Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Injection
1.2.3 Solid Oral Dose Forms
1.2.4 Others
1.3 Cytotoxic Drug Segment by Application
1.3.1 Global Cytotoxic Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other
1.4 Cytotoxic Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Cytotoxic Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Cytotoxic Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Cytotoxic Drug Price Trends (2016-2027)
2 Cytotoxic Drug Estimates and Forecasts by Region
2.1 Global Cytotoxic Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Cytotoxic Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Cytotoxic Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Cytotoxic Drug Revenue Market Share by Region (2016-2021)
2.3 Global Cytotoxic Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Cytotoxic Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Cytotoxic Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Cytotoxic Drug Estimates and Projections (2016-2027)
2.4.2 Europe Cytotoxic Drug Estimates and Projections (2016-2027)
2.4.3 China Cytotoxic Drug Estimates and Projections (2016-2027)
2.4.4 Japan Cytotoxic Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Cytotoxic Drug Estimates and Projections (2016-2027)
2.4.6 India Cytotoxic Drug Estimates and Projections (2016-2027)
3 Global Cytotoxic Drug Competition Landscape by Players
3.1 Global Top Cytotoxic Drug Players by Sales (2016-2021)
3.2 Global Top Cytotoxic Drug Players by Revenue (2016-2021)
3.3 Global Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cytotoxic Drug as of 2020)
3.4 Global Cytotoxic Drug Average Price by Company (2016-2021)
3.5 Manufacturers Cytotoxic Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Cytotoxic Drug Market Size by Type
4.1 Global Cytotoxic Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Cytotoxic Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Cytotoxic Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Cytotoxic Drug Price by Type (2016-2021)
4.2 Global Cytotoxic Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Cytotoxic Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Cytotoxic Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Cytotoxic Drug Price Forecast by Type (2022-2027)
5 Global Cytotoxic Drug Market Size by Application
5.1 Global Cytotoxic Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Cytotoxic Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Cytotoxic Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Cytotoxic Drug Price by Application (2016-2021)
5.2 Global Cytotoxic Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Cytotoxic Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Cytotoxic Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Cytotoxic Drug Price Forecast by Application (2022-2027)
6 North America Cytotoxic Drug Market Facts & Figures
6.1 North America Cytotoxic Drug Sales by Company
6.1.1 North America Cytotoxic Drug Sales by Company (2016-2021)
6.1.2 North America Cytotoxic Drug Revenue by Company (2016-2021)
6.2 North America Cytotoxic Drug Sales Breakdown by Type
6.2.1 North America Cytotoxic Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Cytotoxic Drug Sales Breakdown by Type (2022-2027)
6.3 North America Cytotoxic Drug Sales Breakdown by Application
6.3.1 North America Cytotoxic Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Cytotoxic Drug Sales Breakdown by Application (2022-2027)
7 Europe Cytotoxic Drug Market Facts & Figures
7.1 Europe Cytotoxic Drug Sales by Company
7.1.1 Europe Cytotoxic Drug Sales by Company (2016-2021)
7.1.2 Europe Cytotoxic Drug Revenue by Company (2016-2021)
7.2 Europe Cytotoxic Drug Sales Breakdown by Type
7.2.1 Europe Cytotoxic Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Cytotoxic Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Cytotoxic Drug Sales Breakdown by Application
7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)
8 China Cytotoxic Drug Market Facts & Figures
8.1 China Cytotoxic Drug Sales by Company
8.1.1 China Cytotoxic Drug Sales by Company (2016-2021)
8.1.2 China Cytotoxic Drug Revenue by Company (2016-2021)
8.2 China Cytotoxic Drug Sales Breakdown by Type
8.2.1 China Cytotoxic Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Cytotoxic Drug Sales Breakdown by Type (2022-2027)
8.3 China Cytotoxic Drug Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Cytotoxic Drug Market Facts & Figures
9.1 Japan Cytotoxic Drug Sales by Company
9.1.1 Japan Cytotoxic Drug Sales by Company (2016-2021)
9.1.2 Japan Cytotoxic Drug Revenue by Company (2016-2021)
9.2 Japan Cytotoxic Drug Sales Breakdown by Type
9.2.1 Japan Cytotoxic Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Cytotoxic Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Cytotoxic Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Cytotoxic Drug Market Facts & Figures
10.1 Southeast Asia Cytotoxic Drug Sales by Company
10.1.1 Southeast Asia Cytotoxic Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Cytotoxic Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Cytotoxic Drug Sales Breakdown by Type
10.2.1 Southeast Asia Cytotoxic Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Cytotoxic Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Cytotoxic Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Cytotoxic Drug Market Facts & Figures
11.1 India Cytotoxic Drug Sales by Company
11.1.1 India Cytotoxic Drug Sales by Company (2016-2021)
11.1.2 India Cytotoxic Drug Revenue by Company (2016-2021)
11.2 India Cytotoxic Drug Sales Breakdown by Type
11.2.1 India Cytotoxic Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Cytotoxic Drug Sales Breakdown by Type (2022-2027)
11.3 India Cytotoxic Drug Sales Breakdown by Application
11.3.1 India Cytotoxic Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Cytotoxic Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Cytotoxic Drug Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Cytotoxic Drug Products Offered
12.1.5 Roche Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Cytotoxic Drug Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Celgene
12.3.1 Celgene Corporation Information
12.3.2 Celgene Business Overview
12.3.3 Celgene Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Celgene Cytotoxic Drug Products Offered
12.3.5 Celgene Recent Development
12.4 Sanofi
12.4.1 Sanofi Corporation Information
12.4.2 Sanofi Business Overview
12.4.3 Sanofi Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi Cytotoxic Drug Products Offered
12.4.5 Sanofi Recent Development
12.5 eisai
12.5.1 eisai Corporation Information
12.5.2 eisai Business Overview
12.5.3 eisai Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 eisai Cytotoxic Drug Products Offered
12.5.5 eisai Recent Development
12.6 Sumitomo Dainippon Pharma
12.6.1 Sumitomo Dainippon Pharma Corporation Information
12.6.2 Sumitomo Dainippon Pharma Business Overview
12.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sumitomo Dainippon Pharma Cytotoxic Drug Products Offered
12.6.5 Sumitomo Dainippon Pharma Recent Development
12.7 Merck
12.7.1 Merck Corporation Information
12.7.2 Merck Business Overview
12.7.3 Merck Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Merck Cytotoxic Drug Products Offered
12.7.5 Merck Recent Development
12.8 Seattle Genetics
12.8.1 Seattle Genetics Corporation Information
12.8.2 Seattle Genetics Business Overview
12.8.3 Seattle Genetics Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Seattle Genetics Cytotoxic Drug Products Offered
12.8.5 Seattle Genetics Recent Development
12.9 Takeda
12.9.1 Takeda Corporation Information
12.9.2 Takeda Business Overview
12.9.3 Takeda Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Takeda Cytotoxic Drug Products Offered
12.9.5 Takeda Recent Development
12.10 Haosoh Pharma
12.10.1 Haosoh Pharma Corporation Information
12.10.2 Haosoh Pharma Business Overview
12.10.3 Haosoh Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Haosoh Pharma Cytotoxic Drug Products Offered
12.10.5 Haosoh Pharma Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Business Overview
12.11.3 Novartis Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Cytotoxic Drug Products Offered
12.11.5 Novartis Recent Development
12.12 AstraZeneca
12.12.1 AstraZeneca Corporation Information
12.12.2 AstraZeneca Business Overview
12.12.3 AstraZeneca Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 AstraZeneca Cytotoxic Drug Products Offered
12.12.5 AstraZeneca Recent Development
12.13 Jazz Pharma
12.13.1 Jazz Pharma Corporation Information
12.13.2 Jazz Pharma Business Overview
12.13.3 Jazz Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jazz Pharma Cytotoxic Drug Products Offered
12.13.5 Jazz Pharma Recent Development
12.14 Spectrum Pharma
12.14.1 Spectrum Pharma Corporation Information
12.14.2 Spectrum Pharma Business Overview
12.14.3 Spectrum Pharma Cytotoxic Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Spectrum Pharma Cytotoxic Drug Products Offered
12.14.5 Spectrum Pharma Recent Development
13 Cytotoxic Drug Manufacturing Cost Analysis
13.1 Cytotoxic Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cytotoxic Drug
13.4 Cytotoxic Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cytotoxic Drug Distributors List
14.3 Cytotoxic Drug Customers
15 Market Dynamics
15.1 Cytotoxic Drug Market Trends
15.2 Cytotoxic Drug Drivers
15.3 Cytotoxic Drug Market Challenges
15.4 Cytotoxic Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cytotoxic Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Cytotoxic Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Cytotoxic Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Cytotoxic Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Cytotoxic Drug Sales Market Share by Region (2016-2021)
Table 6. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Cytotoxic Drug Revenue Share by Region (2016-2021)
Table 8. Global Cytotoxic Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Cytotoxic Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Cytotoxic Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Cytotoxic Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Cytotoxic Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Cytotoxic Drug Sales Share by Company (2016-2021)
Table 14. Global Cytotoxic Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Cytotoxic Drug Revenue Share by Company (2016-2021)
Table 16. Global Cytotoxic Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytotoxic Drug as of 2020)
Table 17. Global Cytotoxic Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Cytotoxic Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Cytotoxic Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Cytotoxic Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Cytotoxic Drug Sales Share by Type (2016-2021)
Table 23. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Cytotoxic Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Cytotoxic Drug Sales Share by Type (2022-2027)
Table 26. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Cytotoxic Drug Revenue Share by Type (2022-2027)
Table 28. Global Cytotoxic Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Cytotoxic Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Cytotoxic Drug Sales Share by Application (2016-2021)
Table 31. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Cytotoxic Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Cytotoxic Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Cytotoxic Drug Sales Share by Application (2022-2027)
Table 35. Global Cytotoxic Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Cytotoxic Drug Revenue Share by Application (2022-2027)
Table 37. Global Cytotoxic Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 40. North America Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 44. North America Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 46. North America Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 48. North America Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 62. China Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 63. China Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 64. China Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 66. China Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 68. China Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 70. China Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 72. China Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 98. India Cytotoxic Drug Sales (K Units) by Company (2016-2021)
Table 99. India Cytotoxic Drug Sales Market Share by Company (2016-2021)
Table 100. India Cytotoxic Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Cytotoxic Drug Revenue Market Share by Company (2016-2021)
Table 102. India Cytotoxic Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Cytotoxic Drug Sales Market Share by Type (2016-2021)
Table 104. India Cytotoxic Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Cytotoxic Drug Sales Market Share by Type (2022-2027)
Table 106. India Cytotoxic Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Cytotoxic Drug Sales Market Share by Application (2016-2021)
Table 108. India Cytotoxic Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Cytotoxic Drug Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Roche Cytotoxic Drug Product
Table 114. Roche Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Eli Lilly Cytotoxic Drug Product
Table 119. Eli Lilly Recent Development
Table 120. Celgene Corporation Information
Table 121. Celgene Description and Business Overview
Table 122. Celgene Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Celgene Cytotoxic Drug Product
Table 124. Celgene Recent Development
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Business Overview
Table 127. Sanofi Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Sanofi Cytotoxic Drug Product
Table 129. Sanofi Recent Development
Table 130. eisai Corporation Information
Table 131. eisai Description and Business Overview
Table 132. eisai Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. eisai Cytotoxic Drug Product
Table 134. eisai Recent Development
Table 135. Sumitomo Dainippon Pharma Corporation Information
Table 136. Sumitomo Dainippon Pharma Description and Business Overview
Table 137. Sumitomo Dainippon Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Sumitomo Dainippon Pharma Cytotoxic Drug Product
Table 139. Sumitomo Dainippon Pharma Recent Development
Table 140. Merck Corporation Information
Table 141. Merck Description and Business Overview
Table 142. Merck Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Merck Cytotoxic Drug Product
Table 144. Merck Recent Development
Table 145. Seattle Genetics Corporation Information
Table 146. Seattle Genetics Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Seattle Genetics Description and Business Overview
Table 148. Seattle Genetics Cytotoxic Drug Product
Table 149. Seattle Genetics Recent Development
Table 150. Takeda Corporation Information
Table 151. Takeda Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Takeda Description and Business Overview
Table 153. Takeda Cytotoxic Drug Product
Table 154. Takeda Recent Development
Table 155. Haosoh Pharma Corporation Information
Table 156. Haosoh Pharma Description and Business Overview
Table 157. Haosoh Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Haosoh Pharma Cytotoxic Drug Product
Table 159. Haosoh Pharma Recent Development
Table 160. Novartis Corporation Information
Table 161. Novartis Description and Business Overview
Table 162. Novartis Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Novartis Cytotoxic Drug Product
Table 164. Novartis Recent Development
Table 165. AstraZeneca Corporation Information
Table 166. AstraZeneca Description and Business Overview
Table 167. AstraZeneca Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. AstraZeneca Cytotoxic Drug Product
Table 169. AstraZeneca Recent Development
Table 170. Jazz Pharma Corporation Information
Table 171. Jazz Pharma Description and Business Overview
Table 172. Jazz Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Jazz Pharma Cytotoxic Drug Product
Table 174. Jazz Pharma Recent Development
Table 175. Spectrum Pharma Corporation Information
Table 176. Spectrum Pharma Description and Business Overview
Table 177. Spectrum Pharma Cytotoxic Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Spectrum Pharma Cytotoxic Drug Product
Table 179. Spectrum Pharma Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Cytotoxic Drug Distributors List
Table 183. Cytotoxic Drug Customers List
Table 184. Cytotoxic Drug Market Trends
Table 185. Cytotoxic Drug Market Drivers
Table 186. Cytotoxic Drug Market Challenges
Table 187. Cytotoxic Drug Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Cytotoxic Drug Product Picture
Figure 2. Global Cytotoxic Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cytotoxic Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Breast Cancer Examples
Figure 7. Blood Cancer Examples
Figure 8. Prostate Cancer Examples
Figure 9. Respiratory/Lung Cancer Examples
Figure 10. Other Examples
Figure 11. Global Cytotoxic Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cytotoxic Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Cytotoxic Drug Sales (K Units) Growth Rate (2016-2027)
Figure 14. Global Cytotoxic Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 15. Global Cytotoxic Drug Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Cytotoxic Drug Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Cytotoxic Drug Sales (K Units) Growth Rate (2016-2027)
Figure 19. Europe Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Cytotoxic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Cytotoxic Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Cytotoxic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Cytotoxic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Cytotoxic Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Cytotoxic Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Cytotoxic Drug Players Market Share by Revenue in Cytotoxic Drug: 2016 & 2020
Figure 30. Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Cytotoxic Drug Revenue Share by Type (2016-2021)
Figure 32. Global Cytotoxic Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Cytotoxic Drug Revenue Share by Application (2016-2021)
Figure 34. Global Cytotoxic Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Cytotoxic Drug Sales Market Share by Type in 2020
Figure 36. North America Cytotoxic Drug Sales Market Share by Application in 2020
Figure 37. Europe Cytotoxic Drug Sales Market Share by Type in 2020
Figure 38. Europe Cytotoxic Drug Sales Market Share by Application in 2020
Figure 39. China Cytotoxic Drug Sales Market Share by Type in 2020
Figure 40. China Cytotoxic Drug Sales Market Share by Application in 2020
Figure 41. Japan Cytotoxic Drug Sales Market Share by Type in 2020
Figure 42. Japan Cytotoxic Drug Sales Market Share by Application in 2020
Figure 43. Southeast Asia Cytotoxic Drug Sales Market Share by Type in 2020
Figure 44. Southeast Asia Cytotoxic Drug Sales Market Share by Application in 2020
Figure 45. India Cytotoxic Drug Sales Market Share by Type in 2020
Figure 46. India Cytotoxic Drug Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Cytotoxic Drug
Figure 49. Manufacturing Process Analysis of Cytotoxic Drug
Figure 50. Cytotoxic Drug Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
世界の乳がん診断＆薬物技術市場規模・現状・予測（2021年-2027年） Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on. Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market The global Breast Cancer Diagno…- 乳がん診断および薬物技術のグローバル市場：規模・現状・予測2019-2025 Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to rea…
- 乳がん診断および薬物技術のグローバル市場：規模・現状・予測2019-2025 Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to rea…
- 世界のがん生物毒素治療薬市場規模・現状・予測（2021年-2027年） Treatment of cancer disease depends on the stage of disease progression. Chemotherapy is widely used in earlier stages but there are other therapy options like immunological therapy and targeted drugs used in later stages. Market Analysis and Insights: Global Cancer Biological Toxins Drug Market The…
- 世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…